Ticagrelor, a new antiplatelet agent, for prevention of ischemic events in patients with coronary artery disease

Journal article

Peer reviewed

Harold P Adams Jr

Current neurology and neuroscience reports, Vol.10(1), pp.4-6

01/2010

DOI: 10.1007/s11910-009-0082-x

PMID: 20425218

View Online

no abstract | Clinical Trial Report

Double-Blind Method

Drug Administration Schedule

Follow-Up Studies

Ticlopidine - therapeutic use

Humans

Proportional Hazards Models

Male

Treatment Outcome

Ischemia - prevention & control

Ticlopidine - analogs & derivatives

Time Factors

Adenosine - analogs & derivatives

Adenosine - therapeutic use

Coronary Artery Disease - complications

Female

Platelet Aggregation Inhibitors - therapeutic use

Ischemia - etiology

Title: Subtitle: Ticagrelor, a new antiplatelet agent, for prevention of ischemic events in patients with coronary artery disease
Creators: Harold P Adams Jr - Division of Cerebrovascular Diseases, Department of Neurology, University of Iowa Stroke Center, University of Iowa, 200 Hawkings Drive, Iowa City, IA, 52242, USA. harold-adams@uiowa.edu
Resource Type: Journal article
Publication Details: Current neurology and neuroscience reports, Vol.10(1), pp.4-6
Publisher: United States
DOI: 10.1007/s11910-009-0082-x
PMID: 20425218
ISSN: 1528-4042
eISSN: 1534-6293
Language: English
Date published: 01/2010
Academic Unit: Neurology; Iowa Neuroscience Institute
Record Identifier: 9984020625902771

7 Record Views